These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29217666)

  • 1. EPAC1 regulates endothelial annexin A2 cell surface translocation and plasminogen activation.
    Yang W; Mei FC; Cheng X
    FASEB J; 2018 Apr; 32(4):2212-2222. PubMed ID: 29217666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exchange protein directly activated by cAMP plays a critical role in regulation of vascular fibrinolysis.
    He X; Drelich A; Yu S; Chang Q; Gong D; Zhou Y; Qu Y; Yuan Y; Su Z; Qiu Y; Tang SJ; Gaitas A; Ksiazek T; Xu Z; Zhou J; Feng Z; Wakamiya M; Lu F; Gong B
    Life Sci; 2019 Mar; 221():1-12. PubMed ID: 30738042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. S100A10, annexin A2, and annexin a2 heterotetramer as candidate plasminogen receptors.
    Kwon M; MacLeod TJ; Zhang Y; Waisman DM
    Front Biosci; 2005 Jan; 10():300-25. PubMed ID: 15574370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annexin II: a plasminogen-plasminogen activator co-receptor.
    Kim J; Hajjar KA
    Front Biosci; 2002 Feb; 7():d341-8. PubMed ID: 11815288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reciprocal modulation of surface expression of annexin A2 in a human umbilical vein endothelial cell-derived cell line by eicosapentaenoic acid and docosahexaenoic acid.
    Park J; Yamaura T; Kawamoto J; Kurihara T; Sato SB
    PLoS One; 2014; 9(1):e85045. PubMed ID: 24465474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of the annexin A2 heterotetramer in vascular fibrinolysis.
    Madureira PA; Surette AP; Phipps KD; Taboski MA; Miller VA; Waisman DM
    Blood; 2011 Nov; 118(18):4789-97. PubMed ID: 21908427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2.
    Belvedere R; Morretta E; Pessolano E; Novizio N; Tosco A; Porta A; Whiteford J; Perretti M; Filippelli A; Monti MC; Petrella A
    J Cell Physiol; 2021 Jul; 236(7):4926-4943. PubMed ID: 33284486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
    He KL; Deora AB; Xiong H; Ling Q; Weksler BB; Niesvizky R; Hajjar KA
    J Biol Chem; 2008 Jul; 283(28):19192-200. PubMed ID: 18434302
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospholipid-associated annexin A2-S100A10 heterotetramer and its subunits: characterization of the interaction with tissue plasminogen activator, plasminogen, and plasmin.
    MacLeod TJ; Kwon M; Filipenko NR; Waisman DM
    J Biol Chem; 2003 Jul; 278(28):25577-84. PubMed ID: 12730231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2.
    Peterson EA; Sutherland MR; Nesheim ME; Pryzdial EL
    J Cell Sci; 2003 Jun; 116(Pt 12):2399-408. PubMed ID: 12724354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpesviruses enhance fibrin clot lysis.
    Gershom ES; Vanden Hoek AL; Meixner SC; Sutherland MR; Pryzdial EL
    Thromb Haemost; 2012 Apr; 107(4):760-8. PubMed ID: 22318336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Feedback regulation of endothelial cell surface plasmin generation by PKC-dependent phosphorylation of annexin A2.
    He KL; Sui G; Xiong H; Broekman MJ; Huang B; Marcus AJ; Hajjar KA
    J Biol Chem; 2011 Apr; 286(17):15428-39. PubMed ID: 21115493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endothelial cell annexin A2 system and vascular fibrinolysis.
    Dassah M; Deora AB; He K; Hajjar KA
    Gen Physiol Biophys; 2009; 28 Spec No Focus(SPEC):F20-8. PubMed ID: 20093722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin A2-S100A10 heterotetramer is upregulated by PML/RARĪ± fusion protein and promotes plasminogen-dependent fibrinolysis and matrix invasion in acute promyelocytic leukemia.
    Huang D; Yang Y; Sun J; Dong X; Wang J; Liu H; Lu C; Chen X; Shao J; Yan J
    Front Med; 2017 Sep; 11(3):410-422. PubMed ID: 28687976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of plasmin generation by S100A10.
    Miller VA; Madureira PA; Kamaludin AA; Komar J; Sharma V; Sahni G; Thelwell C; Longstaff C; Waisman DM
    Thromb Haemost; 2017 Jun; 117(6):1058-1071. PubMed ID: 28382372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ANXA2/S100A10 Complex-Regulation of the Oncogenic Plasminogen Receptor.
    Bharadwaj AG; Kempster E; Waisman DM
    Biomolecules; 2021 Nov; 11(12):. PubMed ID: 34944416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the fibrinolytic receptor, annexin II, with the endothelial cell surface. Essential role of endonexin repeat 2.
    Hajjar KA; Guevara CA; Lev E; Dowling K; Chacko J
    J Biol Chem; 1996 Aug; 271(35):21652-9. PubMed ID: 8702954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the contribution of S100A10 and annexin A2 to plasminogen activation and oncogenesis: an enduring ambiguity.
    Bydoun M; Waisman DM
    Future Oncol; 2014 Dec; 10(15):2469-79. PubMed ID: 25525855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of Ion Channels and Receptors by p11 (S100A10).
    Seo JS; Svenningsson P
    Trends Pharmacol Sci; 2020 Jul; 41(7):487-497. PubMed ID: 32418644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The annexin A2 system and angiogenesis.
    Liu W; Hajjar KA
    Biol Chem; 2016 Oct; 397(10):1005-16. PubMed ID: 27366903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.